Pacira Pharmaceuticals, Inc.
SEC CIK 1396814 · PCRX · last insider filing 2026-06-12
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Wiggans Thomas G | Director | filed 2026 - 2026 |
| Brege Laura | Director | filed 2011 - 2026 |
| Yang Michael J. | Director | filed 2023 - 2026 |
| Froimson Mark | Director | filed 2017 - 2026 |
| Hirawat Samit | Director | filed 2026 - 2026 |
| Christie Christopher | Director | filed 2019 - 2026 |
| Young Alethia | Director | filed 2023 - 2026 |
| Bigal Marcelo | Director | filed 2023 - 2026 |
| Kronenfeld Mark A. | Director | filed 2013 - 2026 |
| Lee Frank D. | Director · Chief Executive Officer | filed 2024 - 2026 |
| Ceesay Abraham | Director | filed 2023 - 2025 |
| Hastings Paul J | Director | filed 2011 - 2024 |
| Pace Gary W | Director | filed 2011 - 2024 |
| Stack David M | Director · President, CEO and Chairman | filed 2011 - 2023 |
| Greenstreet Yvonne | Director | filed 2014 - 2022 |
| Longenecker John P PHD | Director | filed 2011 - 2022 |
| Wicki Andreas | Director | filed 2011 - 2021 |
| Winger Dennis L | Director | filed 2013 - 2017 |
| Patou Gary | Director · Chief Medical Officer | filed 2011 - 2014 |
| Middleton Fred A | Director | filed 2011 - 2013 |
| Evnin Luke | Director | filed 2011 - 2013 |
| Sanderling Venture Partners VI Co Investment Fund LP | Director | filed 2011 - 2013 |
| Sanderling Venture Partners VI LP | Director | filed 2011 - 2013 |
| Sanderling VI Limited Partnership | Director | filed 2011 - 2013 |
| Sanderling VI Beteiligungs Gmbh & Co KG | Director | filed 2011 - 2013 |
| Sanderling Ventures Management VI | Director | filed 2011 - 2013 |
| Gordon Carl L | Director | filed 2011 - 2011 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Riker Lauren Bullaro | Vice President, Finance | filed 2012 - 2026 |
| Williams Kristen Marie | Chief Administrative Officer | filed 2014 - 2026 |
| Slonin Jonathan | Chief Medical Officer | filed 2021 - 2026 |
| Cross Shawn | Chief Financial Officer | filed 2024 - 2026 |
| Teehan Brendan | Chief Commercial Officer | filed 2025 - 2026 |
| Gaugler Daryl | Chief Operating Officer | filed 2022 - 2025 |
| Reinhart Charles A. III | Chief Financial Officer | filed 2016 - 2024 |
| Winston ROY | Chief Medical Officer | filed 2018 - 2023 |
| Mcloughlin Dennis | Chief Customer Officer | filed 2018 - 2023 |
| Reinhardt MAX | President, Rest of World | filed 2019 - 2023 |
| Ellis Ronald J. Jr. | Chief Strategy Officer | filed 2023 - 2023 |
| Molloy Anthony | Chief Lgl & Compliance Officer | filed 2021 - 2023 |
| Laranjeira Charles Anthony | SVP, Technical Operations | filed 2018 - 2022 |
| Manning Donald C. | Chief Medical Officer | filed 2020 - 2021 |
| Scranton Richard | Chief Scientific Officer | filed 2017 - 2019 |
| Weiland Robert J. | Chief Commercial Officer | filed 2016 - 2018 |
| Braunstein Scott | SVP, Strategy & Corp. Dev. | filed 2015 - 2018 |
| Jones James B | SVP & Chief Medical Officer | filed 2015 - 2017 |
| Scibetta James S | SVP, Chief Financial Officer | filed 2011 - 2017 |
| Markvicka Taunia | Vice President, Commercial | filed 2012 - 2015 |
| Pratt John | General Manager, San Diego | filed 2012 - 2013 |
| Lambert William | SVP, Pharmaceutical Dev | filed 2011 - 2011 |
| Walters Mark | SVP, Technicnical Operations | filed 2011 - 2011 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.